UK markets close in 7 hours 47 minutes

Atara Biotherapeutics, Inc. (ATRA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.7147-0.0039 (-0.54%)
At close: 04:00PM EDT
0.7147 0.00 (0.00%)
After hours: 04:02PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
8,573
8,573
63,573
20,340
0
Cost of revenue
8,886
8,886
0
-
-
Gross profit
-313
-313
63,573
-
-
Operating expenses
Research development
224,785
224,785
272,533
282,001
244,650
Selling general and administrative
50,908
50,908
71,553
78,801
64,402
Total operating expenses
275,693
275,693
344,086
360,802
309,052
Operating income or loss
-276,006
-276,006
-280,513
-340,462
-309,052
Interest expense
5,285
5,285
373
-
-
Total other income/expenses net
-246
-246
49,537
-
-
Income before tax
-276,111
-276,111
-228,290
-340,095
-306,605
Income tax expense
15
15
12
46
15
Income from continuing operations
-276,126
-276,126
-228,302
-340,141
-306,620
Net income
-276,126
-276,126
-228,302
-340,141
-306,620
Net income available to common shareholders
-276,126
-276,126
-228,302
-340,141
-306,620
Basic EPS
-2.78
-
-2.24
-3.63
-4.15
Diluted EPS
-2.78
-
-2.24
-3.63
-4.15
Basic average shares
104,670
-
101,990
93,670
73,973
Diluted average shares
104,670
-
101,990
93,670
73,973